DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 2,042 filers reported holding DANAHER CORPORATION in Q3 2023. The put-call ratio across all filers is 0.89 and the average weighting 0.6%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,325,724 | +3.4% | 65,803 | 0.0% | 0.20% | +4.2% |
| Q2 2023 | $15,792,720 | -37.8% | 65,803 | -34.7% | 0.19% | -39.0% |
| Q1 2023 | $25,406,388 | -26.8% | 100,803 | -22.9% | 0.31% | -36.6% |
| Q4 2022 | $34,717,732 | +3.5% | 130,803 | +0.7% | 0.49% | -14.4% |
| Q3 2022 | $33,545,000 | +26.2% | 129,876 | +23.8% | 0.57% | +34.0% |
| Q2 2022 | $26,588,000 | -10.3% | 104,876 | +3.8% | 0.43% | +24.2% |
| Q1 2022 | $29,636,000 | +11.2% | 101,034 | +24.7% | 0.34% | -11.6% |
| Q4 2021 | $26,660,000 | +8.1% | 81,034 | 0.0% | 0.39% | +2.9% |
| Q3 2021 | $24,669,000 | +124.0% | 81,034 | +97.5% | 0.38% | +131.3% |
| Q2 2021 | $11,011,000 | -4.1% | 41,034 | -19.6% | 0.16% | -1.8% |
| Q1 2021 | $11,486,000 | +1.3% | 51,034 | 0.0% | 0.17% | -17.0% |
| Q4 2020 | $11,336,000 | -8.9% | 51,034 | -11.7% | 0.20% | -42.5% |
| Q3 2020 | $12,445,000 | +17.3% | 57,794 | -3.7% | 0.35% | +39.2% |
| Q2 2020 | $10,609,000 | +50.3% | 60,000 | +17.6% | 0.25% | +18.5% |
| Q1 2020 | $7,058,000 | -54.9% | 51,000 | -50.0% | 0.21% | -30.1% |
| Q4 2019 | $15,654,000 | +261.4% | 102,000 | +240.0% | 0.30% | +357.6% |
| Q3 2019 | $4,332,000 | +1.0% | 30,000 | 0.0% | 0.07% | -22.4% |
| Q2 2019 | $4,287,000 | +8.3% | 30,000 | 0.0% | 0.08% | +21.4% |
| Q1 2019 | $3,960,000 | -37.0% | 30,000 | -48.3% | 0.07% | -61.7% |
| Q3 2018 | $6,281,000 | +9.9% | 58,000 | 0.0% | 0.18% | +35.6% |
| Q2 2018 | $5,714,000 | +0.6% | 58,000 | 0.0% | 0.14% | +57.0% |
| Q1 2018 | $5,678,000 | +5.5% | 58,000 | 0.0% | 0.09% | +6.2% |
| Q4 2017 | $5,383,000 | – | 58,000 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 217,436 | $53,823,432 | 13.80% |
| Defender Capital, LLC. | 152,962 | $37,949,802 | 13.74% |
| Bancreek Capital Management, LP | 60,890 | $15,106,809 | 13.58% |
| BOONE CAPITAL MANAGEMENT LLC | 129,163 | $32,045,340 | 10.11% |
| Eagle Health Investments LP | 175,085 | $43,438,589 | 9.57% |
| Third Point | 2,450,000 | $607,845,000 | 9.22% |
| Clio Asset Management LLC | 41,695 | $10,344,530 | 9.04% |
| Consulta Ltd | 500,000 | $124,050,000 | 8.91% |
| Riverstone Advisors, LLC | 47,960 | $11,799,701 | 8.16% |
| CADEN CAPITAL PARTNERS, LP | 123,755 | $27,215,377 | 7.66% |